Disease/Infection News

RSS

B.1.427/B.1.429 variant of SARS-CoV-2 evades neutralization via disulfide bond rearrangement

A new paper discusses an intriguing new mechanism of immune evasion traceable to specific mutations in the B.1.427/B.1.429 variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

7 Jul 2021

Mapping dengue fever hot spots can predict future outbreaks of Zika and chikungunya

Data from nine cities in Mexico confirms that identifying dengue fever “hot spots” can provide a predictive map for future outbreaks of Zika and chikungunya. All three of these viral diseases are spread by the Aedes aegypti mosquito.

7 Jul 2021

Mathematical modeling helped inform early statewide policies to reduce COVID-19 transmission

Colorado researchers have published new findings in Emerging Infectious Diseases that take a first look at the use of SARS-CoV-2 mathematical modeling to inform early statewide policies enacted to reduce the spread of the Coronavirus pandemic in Colorado.

7 Jul 2021

Can memory T cell responses to seasonal coronaviruses protect against severe COVID-19?

In a recent study published in the journal Science Immunology, scientists have revealed that the presence of CD8+ T cells against conserved epitopes of seasonal coronaviruses is associated with mild coronavirus disease 2019 (COVID-19). These immune cells exhibit a memory phenotype and provide protection against severe disease.

7 Jul 2021

Mother-to-baby SARS-CoV-2 transmission in pregnancy possible but rare, says study

A new meta-analysis, released on the medRxiv* preprint server, suggests that, though possible, the virus is rarely transmitted to the newborn in real life. A scientific brief from the World Health Organization (WHO) in February 2021 describes three mechanisms by which the virus might be transmitted from the mother to the fetus or newborn.

7 Jul 2021

New study reports low SARS-CoV-2 breakthrough infections in vaccinated healthcare workers

Researchers examined cases of SARS-CoV-2 infection in fully and partially vaccinated healthcare workers, finding that vaccination provided strong immunity to the virus even though VOCs are on the rise in the non-vaccinated community at large.

7 Jul 2021

Study explores loneliness among men in the COVID-19 pandemic

A recent study from the University of York, UK, has taken on an underexplored area regarding the prevalence, and associated factors of loneliness, among men in the context of the coronavirus disease 2019 (COVID-19) pandemic.

7 Jul 2021

Will the US’s COVID-19 vaccination campaign be undermined by novel SARS-CoV-2 variants of concern?

New research from Arizona State University, USA, uses a novel mathematical model to predict the impact of vaccination and vaccine-induced cross-protection on the B.1.1.7 variant and other SARS-CoV-2 variants circulating in the US as of June 2021. The study has been published in medRxiv* preprint server, while it undergoes peer review.

7 Jul 2021

Discovery of SARS-CoV-2–induced pathways uncovers groundbreaking drug repurposing strategies

A new study has been published in Science Advances that exploits proteomics datasets to develop an agnostic network for SARS-CoV-2–induced pathways, thereby unveiling novel targets and potential repurposing strategies.

7 Jul 2021

AANA-VirtaMed Collaboration Results in Better Surgical Training

The enhanced training modules will be demonstrated at the AOSSM-AANA 2021 Combined Annual Meeting.

From VirtaMed 7 Jul 2021

California’s highest covid infection rates shift to rural counties

Most of us are familiar with the good news: In recent weeks, rates of covid-19 infection and death have plummeted in California, falling to levels not seen since the early days of the pandemic.

7 Jul 2021

Study shows behavioral and physiological impacts from COVID-19 infection can last over 79 days

Analysis of resting heart rate, activity, and sleep patterns, show infected individuals experienced delayed recovery following COVID-19 infection.

7 Jul 2021

Study explores the prevalence of long COVID in England

A review of long COVID studies conducted in March 2021 summarized the available literature on the persistent symptoms after acute COVID-19. The review also reported that most studies included hospitalized patients who had a higher prevalence of persistent symptoms compared to two community-based studies.

7 Jul 2021

Study addresses potential interrelations between AID/APOBECs and the SARS-CoV-2 virus

Together with their multifaceted action mechanisms, activation-induced cytidine deaminase (AID) and so-called APOBEC proteins are important factors in the body's immune response and offer fast and effective protection against a large number of DNA and RNA viruses.

7 Jul 2021

Real-world evidence for effectiveness of vaccination against 4 SARS-CoV-2 VOCs in Canada

Toronto-based researchers recently conducted a study to determine the effectiveness of BNT162b2 (Pfizer-BioNTech), mRNA-1273 (Moderna), and ChAdOx1 (AstraZeneca) vaccines against symptomatic COVID-19 infection caused by the Alpha, Beta, Gamma, and Delta variants between December 2020 to May 2021.

7 Jul 2021

Vaccinate big cats? New report shows SARS-CoV-2 Delta variant infecting endangered lions

There is evidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infecting animals such as ferrets, fruit bats, and cats. New research led by Vijendra Pal Singh from the ICAR-National Institute of High Security Animal Disease in India suggests it might be time to vaccinate the big cats as well. Their report details SARS-CoV-2 infection in nine Asiatic lions caused by the SARS-CoV-2 Delta variant (B.1.617.2).

7 Jul 2021

SARS-CoV-2 Lambda variant spreading rapidly in South America, report reveals

A new research paper by researchers in Peru describes a new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) known as the Lambda variant (C.37). The Lambda variant was first reported in Lima, Peru, in December 2020, and from April 2021, nearly all the coronavirus infections in the country are caused by it.

7 Jul 2021

Interleukin-6 antagonists benefit hospitalized patients with COVID-19

Findings from a study published today [6 July] in the Journal of the American Medical Association (JAMA) have prompted new World Health Organization (WHO) recommendations to use interleukin-6 antagonists in patients with severe or critical COVID-19 along with corticosteroids.

7 Jul 2021

Study shows antibody titers after natural SARS-CoV-2 infection last longer than previously thought

A recent study by researchers from the United Kingdom (UK) revealed that antibody levels associated with protection against reinfection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are likely to last from 1.5 to 2 years on average and that the protection from severe infection may be present for several years.

7 Jul 2021

COVID-19 vaccination may be stemming evolution of “fitter” SARS-CoV-2 variants

Researchers in the United States and India have presented the first known evidence that the rollout of coronavirus disease 2019 (COVID-19) vaccination is restricting the evolutionary and immune escape pathways accessible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

6 Jul 2021

Disease/Infection News

B.1.427/B.1.429 variant of SARS-CoV-2 evades neutralization via disulfide bond rearrangement

Mapping dengue fever hot spots can predict future outbreaks of Zika and chikungunya

Mathematical modeling helped inform early statewide policies to reduce COVID-19 transmission

Can memory T cell responses to seasonal coronaviruses protect against severe COVID-19?

Mother-to-baby SARS-CoV-2 transmission in pregnancy possible but rare, says study

New study reports low SARS-CoV-2 breakthrough infections in vaccinated healthcare workers

Study explores loneliness among men in the COVID-19 pandemic

Will the US’s COVID-19 vaccination campaign be undermined by novel SARS-CoV-2 variants of concern?

Discovery of SARS-CoV-2–induced pathways uncovers groundbreaking drug repurposing strategies

AANA-VirtaMed Collaboration Results in Better Surgical Training

California’s highest covid infection rates shift to rural counties

Study shows behavioral and physiological impacts from COVID-19 infection can last over 79 days

Study explores the prevalence of long COVID in England

Study addresses potential interrelations between AID/APOBECs and the SARS-CoV-2 virus

Real-world evidence for effectiveness of vaccination against 4 SARS-CoV-2 VOCs in Canada

Vaccinate big cats? New report shows SARS-CoV-2 Delta variant infecting endangered lions

SARS-CoV-2 Lambda variant spreading rapidly in South America, report reveals

Interleukin-6 antagonists benefit hospitalized patients with COVID-19

Study shows antibody titers after natural SARS-CoV-2 infection last longer than previously thought

COVID-19 vaccination may be stemming evolution of “fitter” SARS-CoV-2 variants

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News